BRCA2 and breast cancer: Chemical inhibition of PARP profoundly inhibited clonogenicity of BRCA2-deficient Chinese hamster VS8 fibroblasts as compared to parental V79 cells. Similar results were obtained upon simultaneous inhibition of BRCA2 and PARP in MCF7 and MDA-MB-231 breast cancer cell lines.